Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029)
Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029) The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Meningococcal group A, C, W-135 and Y conjugate vaccine, required for the vaccinations in the Finnish Defence Forces and the Finnish Border Guard and for the risk group vaccinations in the National Vaccination Programme in Finland. The contract period is two years 2026 - 2027. The procurement contains two one-year contr…
- Ostaja
- Ministry of Social Affairs and Health
- Julkaistu
- 2025-09-26
- Arvo
- 2 485 056 EUR
- Suorituspaikka
- Uusimaa
- Ilmoitus
- 30700
Voittajat ja hankinnan osat
Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029)
The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Meningococcal group A, C, W-135 and Y conjugate vaccine, required for the vaccinations in the Finnish Defence Forces and the Finnish Border Guard and for the risk group vaccinations in the National Vaccination Programme in Finland. The contract period is two years 2026 - 2027. The procurement contains two one-…
- GlaxoSmithKline Oy (0108378-4) – 2 485 056 €